Clinical Trials on Hepatocellular Cancer (HCC) in Netherlands

Total 1742 results

Leiden University Medical Center
Medtronic; ZonMw: The Netherlands Organisation for Health Research and Development and other collaborators

Completed

Holmium Radioembolization as Adjuvant Treatment to RFA for Early Stage HCC: Dose Finding Study (HORA EST HCC)

HCC | Early Stage HCC

Netherlands
Radboud University Medical Center
Terumo Medical Corporation

Enrolling by invitation

MRI-guided Holmium-166 Radioembolization (EMERITUS-2)

Primary Liver Cancer | Non-Resectable Hepatocellular Carcinoma

Netherlands
Genentech, Inc.

Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Melanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCC

Korea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
Leiden University Medical Center
Mirada Medical

Completed

Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous Ablation (IAMCOMPLETE)

HCC

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...
Erasmus Medical Center

Terminated

Sorafenib PK in Patients With Advanced HCC and Child-Pugh B (SORBE)

BCLC Stage C HCC | CP-B Liver Cirrhosis

Netherlands
UMC Utrecht
Erasmus Medical Center; Terumo Corporation

Recruiting

Individualized Dosimetry for Holmium-166-radioembolization in Patients With Unresectable Hepatocellular Carcinoma (iHEPAR)

Hepatocellular Carcinoma Non-resectable

Netherlands
UMC Utrecht
Erasmus Medical Center; Dutch Cancer Society; Quirem Medical B.V.

Completed

HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma Patients

Hepatocellular Carcinoma | Hepatocellular Carcinoma Non-resectable

Netherlands
Leiden University Medical Center
Philips Healthcare; European Commission

Recruiting

Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors (A-IMAGIO)

Hepatocellular Carcinoma | Liver Metastases | Liver Cancer | Liver Metastasis Colon Cancer

Netherlands
Radboud University Medical Center
Merck Sharp & Dohme LLC

Completed

Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO) (PROMO)

HCV Infections | Gastric Acid-related Disorders

Netherlands
Radboud University Medical Center

Withdrawn

Bioequivalence Study of Crushed Sofosbuvir/Velpatasvir Compared to the Whole Tablet (CRUSADE-1)

HCV

Netherlands, Germany
Terumo Europe N.V.

Completed

Holmium-166 Retrospective Collection of Real-World Data (RECORD)

Hepatocellular Carcinoma | Metastatic Cancer

Netherlands, Germany, Switzerland, Belgium, Spain, Portugal, Italy
Maastricht University Medical Center

Completed

Effect of Intermittent Pedicle Clamping on Hepatocellular Injury During Liver Surgery

Blood Loss | Hepatocellular Injury

Netherlands
University of Leipzig
Medical University of Graz; University of Turku; University Medical Center Nijmegen

Unknown

Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment (ClinicIMPPACT)

Hepatocellular Carcinoma | Liver Metastases

Austria, Finland, Germany, Netherlands
Erasmus Medical Center

Enrolling by invitation

Validation of SMS Protocol for HCC Screening in High-risk Patients

Hepatocellular Carcinoma

Netherlands
Boston Scientific Corporation

Completed

Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation

ACC/AHA/NASPE Class 1, IIa or IIb Indications

Netherlands, Italy, United Kingdom, New Zealand
Erasmus Medical Center
Radboud University Medical Center; Universitaire Ziekenhuizen KU Leuven; Maastricht... and other collaborators

Terminated

Transarterial Chemoembolization Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma (TRENDY)

Liver Neoplasms

Netherlands, Belgium, France
Radboud University Medical Center
Merck Sharp & Dohme LLC

Completed

Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir (OPAL)

HIV Infections | HCV Infections

Netherlands
Novartis Pharmaceuticals

Terminated

Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma

United States, Spain, Korea, Republic of, Netherlands, Taiwan
Paul G. Kemps, MD
Juliana Children's Hospital

Active, not recruiting

GastroIntestinal Cancer in Children and Adolescents (GICCA)

Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Burkitt Lymphoma | Neuroendocrine Tumors | Gastrointestinal Cancer | Hepatoblastoma

Netherlands
Impaqtt Foundation
Memorial Sloan Kettering Cancer Center; Novartis; Pfizer; Leiden University Medical... and other collaborators

Completed

Caphosol in Oral Mucositis Due to Targeted Therapy (COMTT)

Renal Cell Carcinoma | Hepatocellular Carcinoma | Gastrointestinal Stromal Tumors | Oral Complaints

Netherlands
Maastricht University Medical Center

Active, not recruiting

T1 Squamous Cell Carcinomas of the Lip

Recurrence | Surgery | Metastasis | Squamous Cell Carcinoma | Lip | Surgical Margin | Lip Cancer | Lip SCC | Squamous Cell Carcinoma of the Lip | Tumor Free Margins

Netherlands
Hoffmann-La Roche

Completed

Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)

HCV Infection

Netherlands
The Netherlands Cancer Institute
Pfizer

Recruiting

Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC

Renal Cell Carcinoma

Netherlands
Boston Scientific Corporation
Biocompatibles UK Ltd

Completed

A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC (TARGET)

Hepatocellular Carcinoma

United States, Switzerland, Germany, France, Italy, Netherlands, Saudi Arabia, Turkey
The Netherlands Cancer Institute

Recruiting

The Prospective Observational COMPRAYA Cohort Study (COMPRAYA)

Cancer | Fertility Issues | Genetic Disease | Lifestyle | Survivorship | Distress, Emotional | Second Cancer

Netherlands
University Medical Center Groningen

Completed

Self-Monitoring Physical Activity With a Smartphone Application and Physiotherapy Coaching in Cancer Patients. (SMART-COACH)

Cancer

Netherlands
Tesaro, Inc.

Completed

Absorption, Metabolism, Excretion, and the Determination of Absolute Bioavailability of Niraparib in Subjects With Cancer

Cancer

Netherlands
Maastricht Radiation Oncology
Maastro Clinic, The Netherlands

Completed

Visual Management for the Radiotherapy Process (VMRTP)

Cancer

Netherlands
University Medical Center Groningen

Recruiting

The Gut Immune System During Immune Checkpoint Inhibitor Therapy (DEFENCE)

Cancer

Netherlands
University Medical Center Groningen

Completed

The Perceived Mismatch Between Dose Recommendations of PKI's and the Clinical Practice

Cancer

Netherlands
University Medical Center Groningen
Nutricia, Inc.

Completed

The Oncoflavour Study

Cancer

Netherlands
University Medical Center Groningen

Completed

Flash Mob Study With Regard to Travel Willingness Among Patients With Cancer

Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Weekly Administration of (bi-)Daily Oral Docetaxel in Combination With Ritonavir

Cancer

Netherlands
Varian, a Siemens Healthineers Company

Completed

Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy (CONFIGURE)

Breast Cancer | Head and Neck Cancer | Lung Cancer | Abdominal Cancer | Pelvic Cancer

Netherlands
University Medical Center Groningen

Recruiting

Eating Experience at the Comprehensive Cancer Center Wards - a Qualitative Study

Cancer

Netherlands
Rijnstate Hospital

Unknown

Validation of an Adjusted Dosing Algorithm of Carboplatin

Cancer

Netherlands
Maastricht Radiation Oncology
Amsterdam UMC, location VUmc

Completed

Non-Invasive Imaging of [18F]HX4 With Positron-Emission-Tomography (PET) (HX-4)

Cancer

Netherlands
Radboud University Medical Center
Terumo Medical Corporation

Completed

Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT (CONTROL)

Primary Liver Cancer | Liver Cancer | Liver Metastasis Colon Cancer

Netherlands
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study (HYPE)

Pancreatic Cancer | Esophageal Cancer | Rectal Cancer

Netherlands
Radboud University Medical Center
University Medical Center Groningen; Maastricht University Medical Center; UMC... and other collaborators

Completed

Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens (RIBACOP)

Hepatitis C | HCV Coinfection

Netherlands
Maastricht Radiation Oncology
Amsterdam UMC, location VUmc

Completed

Non-invasive Imaging of Cetuximab-Zr. 89 Uptake Wit PET: a Phase I Trial in Stage IV Cancer Patients (Cetuximab Zr89)

Stage IV Cancer

Netherlands
Academisch Ziekenhuis Maastricht
Eli Lilly and Company; Novartis; Pfizer; Gilead Sciences; Roche Pharma AG; AstraZeneca and other collaborators

Recruiting

Southeast Netherlands Advanced Metastatic Breast Cancer Registry (SONABRE)

Advanced Breast Cancer | Metastatic Breast Cancer

Netherlands
Incyte Corporation

Completed

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

Head and Neck Cancer | Gastric Cancer | Lung Cancer | Metastatic Cancer | Mesothelioma | Bladder Cancer | Solid Tumors | Renal Cell Carcinoma (RCC) | Colorectal Cancer (CRC) | UC (Urothelial Cancer)

Italy, Spain, United States, Netherlands
Netherlands Open University
Maastricht University Medical Center; Dutch Cancer Society; Maastro Clinic, The... and other collaborators

Completed

The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients

Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer | Non-Hodgkin Lymphoma | Bladder Cancer | Cervix Cancer | Cancer of Skin | Cancer of Endometrium

Netherlands
Erasmus Medical Center
Sanofi

Withdrawn

INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701 (INTRUSION)

Metastatic Lung Cancer | Metastatic Breast Cancer | Metastatic Gastric Cancer

Netherlands
Radboud University Medical Center

Terminated

Real World Pharmacokinetics of Immune Checkpoint Inhibitors (ELICIT)

Cancer

Netherlands
Radboud University Medical Center

Completed

Pazopanib Tolerability When Given With Food (DIET)

Cancer

Netherlands
University Medical Center Groningen

Active, not recruiting

Testosterone & Tamoxifen Trial (T&T)

Male Breast Cancer

Netherlands
Radboud University Medical Center
Dutch Cancer Society

Recruiting

Effectiveness of Blended and Unguided Delivery of Mindfulness-based Cognitive Therapy for Cancer Patients (BUDDY)

Cancer

Netherlands
Eisai Inc.

Completed

Study Of Eribulin (E7389) In Patients With Advanced Solid Tumors And Normal Or Reduced Hepatic Function As Per Child-Pugh System

Cancer

Netherlands

Clinical Trials on Hepatocellular Cancer (HCC) in Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations